Optimized Production of Lentiviral Vectors for CAR-T Cell

8Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Advances in the use of lentiviral vectors for gene therapy applications have created a need for large-scale manufacture of clinical-grade viral vectors for transfer of genetic materials. Lentiviral vectors can transduce a wide range of cell types and integrate into the host genome of dividing and nondividing cells, resulting in long-term expression of the transgene both in vitro and in vivo. In this chapter, we present a method to transfect human cells, creating an easy platform to produce lentiviral vectors for CAR-T cell application.

Cite

CITATION STYLE

APA

Moço, P. D., de Abreu Neto, M. S., Fantacini, D. M. C., & Picanço-Castro, V. (2020). Optimized Production of Lentiviral Vectors for CAR-T Cell. In Methods in Molecular Biology (Vol. 2086, pp. 69–76). Humana Press Inc. https://doi.org/10.1007/978-1-0716-0146-4_5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free